R&G PharmaStudies Co., Ltd. (SHE:301333)
China · Delayed Price · Currency is CNY 48.91
-1.22 (-2.43%)
At close: Jun 2, 2026
R&G PharmaStudies Market Cap
R&G PharmaStudies has a market cap or net worth of 4.69 billion as of June 2, 2026. Its market cap has increased by 7.40% in one year.
Market Cap
4.69B
Enterprise Value
2.99B
Revenue
896.26M
Ranking
n/a
PE Ratio
34.90
Stock Price
48.91
Market Cap Chart
Since August 2, 2022, R&G PharmaStudies's market cap has decreased from 5.40B to 4.69B, a decrease of -13.07%. That is a compound annual growth rate of -3.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 4.69B | -17.13% |
| Dec 31, 2025 | 5.67B | 19.12% |
| Dec 31, 2024 | 4.76B | -23.17% |
| Dec 29, 2023 | 6.19B | 25.30% |
| Dec 30, 2022 | 4.94B | -8.52% |
| Aug 2, 2022 | 5.40B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition